Progressive pulmonary fibrosis is not a diagnosis so much as a disease behavior and a clinical phenotype, says Anna-Maria ...
Australia's first clinical practice guideline on the appropriate use of methylenedioxymethamphetamine-assisted psychotherapy ...
12d
HealthDay on MSNCertain Glucose-Lowering Meds Associated With Lower Risk for COPD ExacerbationsFor patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 ...
For treating pulmonary fibrosis, presently the pharmacological arsenal involves ... that almost 20–30 percent of patients undergoing treatment for pulmonary fibrosis discontinue drugs like ...
With treatment advancements in mind, you should read long-term statistics with an understanding that being diagnosed with lung cancer today means you have a better chance of survival than those ...
"This complicates the diagnosis and treatment process." Some veterans who have been exposed to hazardous materials may also face a higher risk of lung cancer, she noted. "Veterans based in the ...
In COPD, muscular atrophy is a significant risk factor for death and may prolong patients’ hospital length of stay.
Gemelli', demonstrated the onset of bilateral pneumonia that required further pharmacological therapy ... He had part of one lung removed after a pulmonary infection as a young man, making ...
which was "making treatment more challenging". "Nevertheless, Pope Francis remains in good spirits," the Vatican statement added. The pope is especially prone to lung infections because as a young ...
The patients selected for artificial ventilation had not responded to the initial therapy, were cyanotic ... were age-matched infants without known pulmonary disease. Pathologic controls were ...
Pulmonary hypertension (PH ... were developed to treat PAH. Thus, limited treatment data exist for the less-studied non-PAH forms of PH. Pharmacogenomics can be a tool to better understand ...
The choice of systemic agent should individualized and is dependent on the presence of other manifestations of DM, such as myositis or lung involvement ... on JAK inhibitor therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results